Literature DB >> 3534196

Viral and bacterial organisms associated with acute pharyngitis in a school-aged population.

J A McMillan, C Sandstrom, L B Weiner, B A Forbes, M Woods, T Howard, L Poe, K Keller, R M Corwin, J W Winkelman.   

Abstract

To investigate the causes and clinical characteristics of acute pharyngitis among school-aged children (4 to 18 years), we obtained throat cultures for respiratory viruses, Mycoplasma pneumoniae, group A streptococcus, and Chlamydia trachomatis from 320 patients with sore throat and 308 controls without respiratory complaints. The study was conducted from January to April 1985 in a private pediatric practice in central New York State. Sixty percent of the patients and 26% of the control subjects had positive cultures for at least one organism. Forty percent of patients had positive cultures for group A streptococcus, compared with 11.9% of the controls. Fifty (16%) patients had positive viral cultures, compared with eight (2.6%) controls; the predominant viral isolate was influenza A Philippines. Patients infected with influenza A were significantly more likely to complain of cough and hoarseness, and were less likely to have pharyngeal exudate or tender cervical adenopathy, than were patients who had positive cultures for group A streptococcus. Although 49 (15.8%) patients with acute pharyngitis had cultures positive for M. pneumoniae, 53 (17.6%) asymptomatic controls were also had M. pneumoniae-positive cultures. Thus detection of M. pneumoniae in the throat of school-aged children with pharyngitis may not be sufficient to establish a diagnosis of disease caused by this organism. C. trachomatis was not isolated from any patient or control.

Entities:  

Mesh:

Year:  1986        PMID: 3534196     DOI: 10.1016/s0022-3476(86)80687-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

1.  Inverse association between Lancefield group G Streptococcus colonization and sore throat in slum and nonslum settings in Brazil.

Authors:  Sara Yee Tartof; Frances Farrimond; Juliana Arruda de Matos; Joice Neves Reis; Regina Terse Trindade Ramos; Aurelio Nei Andrade; Mitermayer Galvão dos Reis; Lee Woodland Riley
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

2.  High group A streptococcal carriage in the Orthodox Jewish community of north Hackney.

Authors:  J Spitzer; E Hennessy; L Neville
Journal:  Br J Gen Pract       Date:  2001-02       Impact factor: 5.386

3.  A scoring system for predicting group A streptococcal throat infection.

Authors:  F Dobbs
Journal:  Br J Gen Pract       Date:  1996-08       Impact factor: 5.386

4.  Nonstreptococcal pharyngitis.

Authors:  Michael Green
Journal:  Semin Pediatr Infect Dis       Date:  2006-06-03

5.  Evaluation of potential factors contributing to microbiological treatment failure in Streptococcus pyogenes pharyngitis.

Authors:  S M Kuhn; J Preiksaitis; G J Tyrrel; T Jadavji; D Church; H D Davies
Journal:  Can J Infect Dis       Date:  2001-01

6.  Age-related gene expression in Tourette syndrome.

Authors:  Lisa Lit; Amanda Enstrom; Frank R Sharp; Donald L Gilbert
Journal:  J Psychiatr Res       Date:  2008-05-15       Impact factor: 4.791

Review 7.  Chlamydia trachomatis infections in infants.

Authors:  K Numazaki; M A Wainberg; J McDonald
Journal:  CMAJ       Date:  1989-03-15       Impact factor: 8.262

8.  Aetiology of febrile pharyngitis in children: Potential of myxovirus resistance protein A (MxA) as a biomarker of viral infection.

Authors:  Lauri Ivaska; Jussi Niemelä; Johanna Lempainen; Riikka Österback; Matti Waris; Tytti Vuorinen; Jukka Hytönen; Kaisu Rantakokko-Jalava; Ville Peltola
Journal:  J Infect       Date:  2017-01-07       Impact factor: 6.072

9.  Ramsay Hunt syndrome and zoster laryngitis with multiple cranial nerve involvement.

Authors:  Takashi Shinha; Pasala Krishna
Journal:  IDCases       Date:  2015-03-20

Review 10.  Adult and pediatric pharyngitis: a review.

Authors:  R B Vukmir
Journal:  J Emerg Med       Date:  1992 Sep-Oct       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.